Search

Your search keyword '"Braester A"' showing total 1,007 results

Search Constraints

Start Over You searched for: Author "Braester A" Remove constraint Author: "Braester A" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
1,007 results on '"Braester A"'

Search Results

1. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

3. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

6. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

8. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Timing and characteristics of venous thromboembolism after noncancer surgery

11. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

12. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

13. Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia

15. The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group.

16. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

19. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

23. Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

24. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

25. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

29. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

30. The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia

31. Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide and rituximab (FCR) in patients with CLL. A retrospective multicenter 'real-world' study

32. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

33. PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE

34. Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway.

35. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

38. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

39. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

40. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

41. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

42. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

43. The role of blood inflammatory markers in the preoperative diagnosis of acute appendicitis.

44. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

47. Physicians’ lack of knowledge - a possible reason for red blood cell transfusion overuse?

49. Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study

50. A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.

Catalog

Books, media, physical & digital resources